GFM

GF Fund Management Portfolio holdings

AUM $5.85B
1-Year Est. Return 55.85%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+55.85%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.85B
AUM Growth
+$338M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
707
New
Increased
Reduced
Closed

Top Buys

1 +$60.1M
2 +$32.1M
3 +$29.6M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$29M
5
PDD icon
Pinduoduo
PDD
+$28.1M

Top Sells

1 +$77.7M
2 +$53.1M
3 +$24.9M
4
SAP icon
SAP
SAP
+$24.1M
5
BIDU icon
Baidu
BIDU
+$21.5M

Sector Composition

1 Technology 51.21%
2 Communication Services 15.38%
3 Consumer Discretionary 13.01%
4 Healthcare 6.62%
5 Consumer Staples 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TECX
601
Tectonic Therapeutic
TECX
$521M
$7.66K ﹤0.01%
367
-36
RCKT icon
602
Rocket Pharmaceuticals
RCKT
$502M
$7.46K ﹤0.01%
2,125
-196
ALT icon
603
Altimmune
ALT
$438M
$7.4K ﹤0.01%
2,049
+150
BFS
604
Saul Centers
BFS
$841M
$7.06K ﹤0.01%
224
-1
AURA icon
605
Aura Biosciences
AURA
$362M
$6.8K ﹤0.01%
1,247
-89
BCYC
606
Bicycle Therapeutics
BCYC
$371M
$6.44K ﹤0.01%
909
-86
ACRS icon
607
Aclaris Therapeutics
ACRS
$338M
$6.41K ﹤0.01%
+2,128
LRMR icon
608
Larimar Therapeutics
LRMR
$434M
$6.4K ﹤0.01%
1,680
-161
AVXL icon
609
Anavex Life Sciences
AVXL
$441M
$6.25K ﹤0.01%
1,755
-93
NGNE icon
610
Neurogene
NGNE
$343M
$6.22K ﹤0.01%
302
-14
ACIU icon
611
AC Immune
ACIU
$275M
$6.19K ﹤0.01%
1,972
-188
CADL icon
612
Candel Therapeutics
CADL
$355M
$6.09K ﹤0.01%
+1,078
LFCR icon
613
Lifecore Biomedical
LFCR
$263M
$6.02K ﹤0.01%
+736
FHTX icon
614
Foghorn Therapeutics
FHTX
$330M
$6K ﹤0.01%
1,111
-81
MENS
615
Jyong Biotech
MENS
$163M
$5.9K ﹤0.01%
+1,493
PBYI icon
616
Puma Biotechnology
PBYI
$314M
$5.88K ﹤0.01%
+989
NMRA icon
617
Neumora Therapeutics
NMRA
$510M
$5.88K ﹤0.01%
3,282
-202
ALLO icon
618
Allogene Therapeutics
ALLO
$519M
$5.86K ﹤0.01%
4,278
-496
SLN
619
Silence Therapeutics
SLN
$260M
$5.61K ﹤0.01%
922
-56
AARD
620
Aardvark Therapeutics
AARD
$125M
$5.6K ﹤0.01%
+427
AVIR icon
621
Atea Pharmaceuticals
AVIR
$414M
$5.48K ﹤0.01%
1,534
-220
OABI icon
622
OmniAb
OABI
$288M
$5.23K ﹤0.01%
2,828
+241
CTNM
623
Contineum Therapeutics
CTNM
$504M
$5.19K ﹤0.01%
+454
VYGR icon
624
Voyager Therapeutics
VYGR
$219M
$4.63K ﹤0.01%
1,178
-15
OBIO icon
625
Orchestra BioMed
OBIO
$255M
$4.6K ﹤0.01%
+1,109